CERVOMED INC (CRVO) Fundamental Analysis & Valuation

NASDAQ:CRVO • US15713L1098

Current stock price

3.61 USD
-0.11 (-2.96%)
Last:

This CRVO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CRVO Profitability Analysis

1.1 Basic Checks

  • CRVO had negative earnings in the past year.
  • In the past year CRVO has reported a negative cash flow from operations.
  • CRVO had negative earnings in each of the past 5 years.
  • CRVO had a negative operating cash flow in each of the past 5 years.
CRVO Yearly Net Income VS EBIT VS OCF VS FCFCRVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M -25M

1.2 Ratios

  • With a Return On Assets value of -117.86%, CRVO is not doing good in the industry: 80.27% of the companies in the same industry are doing better.
  • The Return On Equity of CRVO (-147.98%) is worse than 62.28% of its industry peers.
Industry RankSector Rank
ROA -117.86%
ROE -147.98%
ROIC N/A
ROA(3y)-59.15%
ROA(5y)-62%
ROE(3y)-72.99%
ROE(5y)-73.02%
ROIC(3y)N/A
ROIC(5y)N/A
CRVO Yearly ROA, ROE, ROICCRVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • CRVO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRVO Yearly Profit, Operating, Gross MarginsCRVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CRVO Health Analysis

2.1 Basic Checks

  • CRVO has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CRVO has been increased compared to 5 years ago.
  • There is no outstanding debt for CRVO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRVO Yearly Shares OutstandingCRVO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
CRVO Yearly Total Debt VS Total AssetsCRVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -4.49, we must say that CRVO is in the distress zone and has some risk of bankruptcy.
  • CRVO has a Altman-Z score of -4.49. This is in the lower half of the industry: CRVO underperforms 60.15% of its industry peers.
  • There is no outstanding debt for CRVO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.49
ROIC/WACCN/A
WACCN/A
CRVO Yearly LT Debt VS Equity VS FCFCRVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • CRVO has a Current Ratio of 4.91. This indicates that CRVO is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.91, CRVO is in line with its industry, outperforming 54.93% of the companies in the same industry.
  • A Quick Ratio of 4.91 indicates that CRVO has no problem at all paying its short term obligations.
  • CRVO has a Quick ratio of 4.91. This is comparable to the rest of the industry: CRVO outperforms 55.90% of its industry peers.
Industry RankSector Rank
Current Ratio 4.91
Quick Ratio 4.91
CRVO Yearly Current Assets VS Current LiabilitesCRVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CRVO Growth Analysis

3.1 Past

  • The earnings per share for CRVO have decreased strongly by -46.80% in the last year.
  • Looking at the last year, CRVO shows a very negative growth in Revenue. The Revenue has decreased by -58.86% in the last year.
EPS 1Y (TTM)-46.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)-58.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.69% on average over the next years. This is quite good.
  • CRVO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 93.70% yearly.
EPS Next Y35.19%
EPS Next 2Y22.76%
EPS Next 3Y16.36%
EPS Next 5Y9.69%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y93.7%

3.3 Evolution

CRVO Yearly Revenue VS EstimatesCRVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
CRVO Yearly EPS VS EstimatesCRVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -500 -1K -1.5K

More info and screens

Find the best growth stocksShow best growing peers

0

4. CRVO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CRVO. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CRVO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRVO Price Earnings VS Forward Price EarningsCRVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRVO Per share dataCRVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CRVO's earnings are expected to grow with 16.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.76%
EPS Next 3Y16.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CRVO Dividend Analysis

5.1 Amount

  • No dividends for CRVO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CRVO Fundamentals: All Metrics, Ratios and Statistics

CERVOMED INC

NASDAQ:CRVO (3/30/2026, 3:18:58 PM)

3.61

-0.11 (-2.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-13
Earnings (Next)05-11
Inst Owners24.14%
Inst Owner Change5.18%
Ins Owners24.03%
Ins Owner Change2.01%
Market Cap33.43M
Revenue(TTM)4.01M
Net Income(TTM)-26.97M
Analysts81.43
Price Target22.59 (525.76%)
Short Float %4.72%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.49%
Min EPS beat(2)-20.3%
Max EPS beat(2)-6.67%
EPS beat(4)1
Avg EPS beat(4)-4.8%
Min EPS beat(4)-20.3%
Max EPS beat(4)16.71%
EPS beat(8)2
Avg EPS beat(8)-8%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-88.31%
Min Revenue beat(2)-98.95%
Max Revenue beat(2)-77.68%
Revenue beat(4)1
Avg Revenue beat(4)-42.01%
Min Revenue beat(4)-98.95%
Max Revenue beat(4)9.17%
Revenue beat(8)4
Avg Revenue beat(8)-8.46%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.27%
PT rev (3m)-1.27%
EPS NQ rev (1m)-36.71%
EPS NQ rev (3m)-36.71%
EPS NY rev (1m)0%
EPS NY rev (3m)3.7%
Revenue NQ rev (1m)-45.45%
Revenue NQ rev (3m)-45.45%
Revenue NY rev (1m)-100%
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.34
P/FCF N/A
P/OCF N/A
P/B 1.83
P/tB 1.83
EV/EBITDA N/A
EPS(TTM)-2.98
EYN/A
EPS(NY)-1.93
Fwd EYN/A
FCF(TTM)-2.53
FCFYN/A
OCF(TTM)-2.53
OCFYN/A
SpS0.43
BVpS1.97
TBVpS1.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -117.86%
ROE -147.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-59.15%
ROA(5y)-62%
ROE(3y)-72.99%
ROE(5y)-73.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.91
Quick Ratio 4.91
Altman-Z -4.49
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y35.19%
EPS Next 2Y22.76%
EPS Next 3Y16.36%
EPS Next 5Y9.69%
Revenue 1Y (TTM)-58.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.58%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y93.7%
EBIT growth 1Y-55.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-130.64%
EBIT Next 3Y-39.4%
EBIT Next 5Y-51.22%
FCF growth 1Y-41.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.86%
OCF growth 3YN/A
OCF growth 5YN/A

CERVOMED INC / CRVO Fundamental Analysis FAQ

What is the fundamental rating for CRVO stock?

ChartMill assigns a fundamental rating of 2 / 10 to CRVO.


Can you provide the valuation status for CERVOMED INC?

ChartMill assigns a valuation rating of 0 / 10 to CERVOMED INC (CRVO). This can be considered as Overvalued.


What is the profitability of CRVO stock?

CERVOMED INC (CRVO) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CRVO stock?

The Earnings per Share (EPS) of CERVOMED INC (CRVO) is expected to grow by 35.19% in the next year.